LDT Oversight: Navigating AI’s Billion Dollar Regulatory Maze
The field for diagnostic AI, once characterized by a patchwork of regulatory interpretations, has undergone a period of significant attempted realignment and subsequent legal challenge.…
The field for diagnostic AI, once characterized by a patchwork of regulatory interpretations, has undergone a period of significant attempted realignment and subsequent legal challenge.…
The FDA’s recent formalization of Predetermined Change Control Plans (PCCPs) marks a key moment for machine learning software in healthcare. This guidance fundamentally reshapes how…
A single phrase in your software description can make the difference between a simple launch and a multi-year FDA clearance process. For digital health innovators,…
The global digital health field presents a paradox: immense opportunity for innovation alongside a labyrinth of regulatory frameworks. For AI health tools, particularly those functioning…
The era of static, locked-down medical software clearances is rapidly drawing to a close. For digital health investors, product managers, and software engineers, understanding this…
The line between a helpful health application and a regulated medical device is often perceived as blurry, yet for digital health developers and product managers,…
The field for AI health tools is rapidly evolving, demanding a sophisticated understanding of regulatory pathways. For digital health companies, working through the FDA’s Software…
The promise of artificial intelligence in healthcare is immense, yet its equitable application remains a critical challenge. As AI-powered clinical tools proliferate, the specter of…
The field for artificial intelligence in healthcare is constantly evolving, nowhere more so than in the nuanced area of diagnostic triage. Recent updates from the…
The digital transformation of healthcare has undeniably accelerated innovation, yet it has also introduced a complex web of cybersecurity vulnerabilities. For medical device manufacturers, particularly…